AU6589200A - Extended release formulation of etodolac - Google Patents

Extended release formulation of etodolac

Info

Publication number
AU6589200A
AU6589200A AU65892/00A AU6589200A AU6589200A AU 6589200 A AU6589200 A AU 6589200A AU 65892/00 A AU65892/00 A AU 65892/00A AU 6589200 A AU6589200 A AU 6589200A AU 6589200 A AU6589200 A AU 6589200A
Authority
AU
Australia
Prior art keywords
etodolac
release formulation
extended release
formulation
extended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65892/00A
Other languages
English (en)
Inventor
Rajeev S. Raghuvanshi
Ashok Rampal
Himadri Sen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN1210DE1999 external-priority patent/IN190974B/en
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU6589200A publication Critical patent/AU6589200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU65892/00A 1999-09-10 2000-08-30 Extended release formulation of etodolac Abandoned AU6589200A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1210/DEL/99 1999-09-10
IN1210DE1999 IN190974B (zh) 1999-09-10 1999-09-10
US09/648,949 US6586005B1 (en) 1999-09-10 2000-08-25 Extended release formulation of etodolac
US09648949 2000-08-25
PCT/IB2000/001208 WO2001019349A2 (en) 1999-09-10 2000-08-30 Extended release formulation of etodolac

Publications (1)

Publication Number Publication Date
AU6589200A true AU6589200A (en) 2001-04-17

Family

ID=26324703

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65892/00A Abandoned AU6589200A (en) 1999-09-10 2000-08-30 Extended release formulation of etodolac

Country Status (3)

Country Link
CN (1) CN1227001C (zh)
AU (1) AU6589200A (zh)
WO (1) WO2001019349A2 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0206505D0 (en) * 2002-03-19 2002-05-01 Euro Celtique Sa Pharmaceutical combination
EA200401334A1 (ru) * 2002-04-11 2005-04-28 Ранбакси Лабораторис Лимитед Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением
WO2007004425A1 (ja) * 2005-06-22 2007-01-11 Takeda Pharmaceutical Company Limited 難溶性の有効成分を含有する錠剤
JP5208729B2 (ja) 2006-04-12 2013-06-12 日本曹達株式会社 徐放性錠剤の製造方法
CN101259113B (zh) * 2008-04-21 2013-02-13 沈阳药科大学 依托度酸渗透泵型控释制剂
TR200908308A1 (tr) 2010-01-18 2011-08-22 Turgut İlaçlari A.Ş. Etodolak içeren sürekli salım tablet formulasyonu
CN102485215B (zh) * 2010-12-03 2013-05-15 沈阳药科大学 依托度酸定时释药微丸制剂及其制备方法
GB201420306D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
CN106727390A (zh) * 2015-11-19 2017-05-31 哈尔滨圣吉药业股份有限公司 一种依托度酸缓释片及其制备方法
CN114699380A (zh) * 2021-12-27 2022-07-05 南京联智医药科技有限公司 一种依托度酸片及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK74396A3 (en) * 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
US6251430B1 (en) * 1998-02-04 2001-06-26 Guohua Zhang Water insoluble polymer based sustained release formulation
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet

Also Published As

Publication number Publication date
CN1402631A (zh) 2003-03-12
WO2001019349A2 (en) 2001-03-22
CN1227001C (zh) 2005-11-16
WO2001019349A3 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
AU3867400A (en) Methods of using bioelastomers
AUPP970099A0 (en) Concrete formulation
AU6314900A (en) Biarylurea derivatives
HUP0203680A3 (en) Controlled release hydrocodone formulations
AU6714700A (en) Cyclopropylindole derivatives
AU1278701A (en) Novel compounds
AU4458700A (en) Uses of phenylglycine derivatives
AU2557500A (en) Methods of making compounds
AU4213299A (en) Controlled release of substances
AU5429000A (en) Novel bicyclonucleoside derivatives
AU6564600A (en) Copolymers of acryloyloxyalkylamino compounds
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU6510400A (en) Slow release microspheres
AU7952800A (en) 2-alkoxybenzene derivatives
AU2001232948A1 (en) Controlled release of drugs
AU6589200A (en) Extended release formulation of etodolac
AU6690300A (en) Copolymers of acryloylaminoalkyl compounds
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU5433699A (en) Spacing of tiles
AU3775500A (en) Setting of gemstones
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU1601801A (en) Methods of preparing crna
AU4081300A (en) Centroid integration
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2109700A (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase